Table 3.
Effects of Annurca Supplement (AMS) on Plasma Cholesterol, Glucose, and Triglyceride Metabolism in Men Subgroup According to Age
| Men (age: 30–45) | Δ (%) | Men (age: 46–60) | Δ (%) | Men (age: 61–83) | Δ (%) | |
|---|---|---|---|---|---|---|
| TC (mg/dL) | ||||||
| t 0 | 228.6 ± 11.5 | 233.6 ± 12.8 | 240.1 ± 13.1 | |||
| t 30 | 174.4 ± 12.5 | −23.9 | 175.7 ± 13.8 | −24.8 | 176.2 ± 14.1 | −26.9 |
| t 60 | 174.6 ± 13.0 | −23.6 | 175.3 ± 12.3 | −25.1 | 175.7 ± 12.5 | −26.8 |
| HDL-C (mg/dL) | ||||||
| t 0 | 42.8 ± 3.7 | 39.1 ± 6.2 | 34.2 ± 5.3 | |||
| t 30 | 61.4 ± 4.4 | +43.2 | 58.6 ± 5.2 | +49.1 | 54.1 ± 4.8 | +58.1 |
| t 60 | 62.1 ± 3.8 | +45.3 | 59.0 ± 5.1 | +50.7 | 53.3 ± 6.2 | +56.2 |
| LDL-C (mg/dL) | ||||||
| t 0 | 168.9 ± 13.0 | 181.1 ± 14.5 | 192.4 ± 13.8 | |||
| t 30 | 109.1 ± 12.7 | −35.4 | 110.8 ± 12.0 | −38.8 | 112.5 ± 14.4 | −41.5 |
| t 60 | 108.3 ± 12.9 | −35.9 | 111.7 ± 13.8 | −38.3 | 112.0 ± 12.9 | −41.8 |
| Glucose (mg/dL) | ||||||
| t 0 | 107.2 ± 13.8 | 112.9 ± 13.6 | 113.4 ± 11.9 | |||
| t 30 | 106.2 ± 12.5 | −0.9 | 111.2 ± 12.4 | −1.2 | 112.2 ± 13.1 | −1.5 |
| t 60 | 106.7 ± 14.6 | −0.5 | 114.4 ± 10.9 | +1.3 | 114.4 ± 10.3 | +0.9 |
| Triglycerides (mg/dL) | ||||||
| t 0 | 98.2 ± 10.5 | 91.1 ± 10.3 | 99.4 ± 10.3 | |||
| t 30 | 98.5 ± 11.2 | +0.3 | 91.7 ± 12.8 | +0.7 | 100.2 ± 13.0 | +0.8 |
| t 60 | 99.5 ± 11.8 | +1.3 | 91.2 ± 11.6 | +0.1 | 99.6 ± 11.5 | +0.2 |
Subjects were administered with two AMS capsules/day for 2 months.
Values are represented as mean ± SD (n = 5).
Results were significantly different at a level of P = .001.